Navigation Links
Decision Resources' Updated Rheumatoid Arthritis Report Now Includes Forecast for Rigel Pharmaceuticals' Fostamatinib Disodium
Date:8/6/2009

WALTHAM, Mass., Aug. 6 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, today released its updated Pharmacor Rheumatoid Arthritis report which now includes patient share and sales forecasts through 2018 for Rigel Pharmaceuticals' investigational novel oral agent, fostamatinib disodium (R788). The report update is based on Rigel Pharmaceuticals' recent announcement regarding additional Phase II clinical data for fostamatinib disodium.

The report finds that, owing to its impressive efficacy, the spleen tyrosine kinase (Syk) inhibitor fostamatinib disodium will likely precede TNF-alpha inhibitors such as Amgen/Wyeth/Takeda's Enbrel and Abbott/Eisai's Humira in the treatment cascade for rheumatoid arthritis. Phase II data shows that fostamatinib disodium's efficacy is comparable to that of currently-available biologic agents in patients with inadequate response to treatment with methotrexate. According to the report, if the agent is priced lower than currently-available biologics, physicians may be willing to prescribe fostamatinib disodium as an alternative to premium-priced biologics.

However, Decision Resources conservatively forecasts that fostamatinib disodium's patient share will reach up to 1.8 percent and it will garner major-market sales of $330 million in 2018.

"Fostamatinib disodium's patient share and sales will be considerably lower than our evaluation of the other novel oral agent in development for rheumatoid arthritis--Pfizer's Jak-3 inhibitor CP-690550," said Decision Resources Analyst Joanna Kim, M.Ed. "Fostamatinib disodium's impact is likely to be less than that of CP-690550 because of uncertainties about its efficacy in the TNF-refractory population and the absence of a head-to-head trial against a TNF-alpha inhibitor."

About Decision Resources


'/>"/>
SOURCE Decision Resources
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. BCBSGA Announces Decision to Cover H1N1 Vaccine Administration
2. PET can help guide treatment decisions for a common pediatric cancer
3. WellPoint Announces Decision to Cover H1N1 Vaccine Administration
4. United States Patent Office Issues Decision in Re-examination Proceedings
5. Providence Service Corporation Comments on U.S. Court of Appeals Decision to Uphold Federal Injunction Blocking Californias 10% Cut in Medi-Cal Payments
6. Stem Cell Decision Opens New Doors, May Spur More Research
7. TriServ Likely to Protest Decision
8. Communicating science to decision makers
9. Brain section multitasks, handling phonetics and decision-making
10. The decision about the incision: Is midline or transverse better for abdominal surgery?
11. Jeff Stewart Joins Decision Resources, Inc. as Chief Information Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... 2013, Paris, France: A new investigational device - the ... the Sapien XT Transcatheter Heart Valve was successfully deployed ... study of its use in high-risk aortic insufficiency reported ... as an anchor to help stabilise the SAPIEN XT ... in the heart are captured between the transcatheter heart ...
(Date:5/24/2013)... Health & Science University highlights an ingenious method to ... highly evasive HIV virus that causes AIDS. The same ... to develop its own HIV vaccine candidate, which has ... latest research finding will be published in the May ... , "A major challenge in developing an effective ...
(Date:5/24/2013)... Houston, TX (PRWEB) May 24, 2013 ... designed for modern, busy mothers who are trying to ... and efficient manner and is ideal for women who ... attention of http://HealthAvenger.com ’s Stan Stevenson, prompting ... home workout plan that contains a wide variety of ...
(Date:5/24/2013)... Indianapolis, IN (PRWEB) May 24, 2013 Electric™ ... Unistraw, is fueling IndyCar Rookie Carlos Munoz and will be ... weekend’s Indianapolis 500 at the Indianapolis Motor Speedway. Munoz, who ... an average speed of 228.342 mph in race, qualifying to ... start in the first row in Sunday’s race. , ...
(Date:5/24/2013)... 2013 DiscountHumidifiers.com, an eCommerce store specializing ... new Broksonic line of humidifiers. These tastefully ... options with two styles to choose from. ... a modern accent piece – yet its functionality is ... styling makes it an inconspicuous humidifying appliance. With the ...
Breaking Medicine News(10 mins):Health News:Feasibility trial reports deployment of new device for TAVI in aortic insufficiency 2Health News:OHSU research highlights promising strategy to help vaccines outsmart HIV 2Health News:Fit Yummy Mummy: Review Examining Holly Rigsby’s Fitness Program Released 2Health News:Unistraw Electric™ Energy Straw Chevy Car Powers Indianapolis 500 Rookie Driver Carlos Munoz 2Health News:Unistraw Electric™ Energy Straw Chevy Car Powers Indianapolis 500 Rookie Driver Carlos Munoz 3Health News:DiscountHumidifiers.com Announces the Launch of the New Broksonic Humidifiers to their Online Store 2
... people with Alzheimer's and psychosis are prone to suffer ... patients with Alzheimer's disease suffer from psychotic symptoms like ... of the condition, linked with more aggressive behaviour, more ... ,Researchers at the Alzheimer's disease Research Center in ...
... people evidence of the harm unhealthy habits do can motivate ... studies on biomarkers indicators of health or disease status ... behaviour. ,They learned that if you reveal factors ... it does encourage people to quit for fear they ...
... people, usually in middle age. People with the disease tend ... not the type of arthritis common in the elderly because// ... system goes awry and attacks the joints, causing severe inflammation ... is also linked to an increased risk of heart disease. ...
... the progress of a catastrophic conditions in organ transplant ... heart transplants develop hardened arteries, a condition// called arteriosclerosis, ... ,A team from the Maryland's Women's Hospital, ... the vitamins during a year-long study. Dr James Fang, ...
... degenerative brain disease that usually begins gradually, causing ... tasks. The disease eventually leads// to confusion, personality ... more difficult as the disease progresses, leaving those ... follow directions. Eventually, most people with Alzheimer’s disease ...
... during pregnancy can increase a mother's risk of having ... were very anxious// in the last three months of ... ,Lead researcher Professor Vivette Glover, of Imperial College, London, ... extreme anxiety, and were frequently feeling scared.According to ...
Cached Medicine News:
(Date:5/23/2013)... May 23, 2013 Neurocrine Biosciences, Inc. (Nasdaq: ... , President and Chief Executive Officer of Neurocrine Biosciences, ... Annual dbAccess Health Care Conference in Boston.   ... 11:20 a.m. Eastern Time / 8:20 a.m. Pacific Time.  The ... Company,s website at http://www.neurocrine.com . If ...
(Date:5/23/2013)... , May 23, 2013  MGC Diagnostics Corporation ... global medical technology company, today scheduled a conference call ... of fiscal year 2013, ended April 30, 2013. The ... May 30, 2013. The Company will report financial results ... the markets close on Thursday, May 30, 2013. ...
(Date:5/23/2013)... SAN DIEGO , May 23, 2013 /PRNewswire/ ... the prostate cancer treatment continuum was highlighted prominently ... the American Urological Association (AUA), in San Diego.  ... invasive high intensity focused ultrasound (HIFU) technology, the ... localize disease, and for urologists to consider minimally ...
Breaking Medicine Technology:MGC Diagnostics Corporation to Report Second Quarter Fiscal 2013 Financial Results on Thursday, May 30, 2013 2Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 2Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 3Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 4Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 5Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 6
... 18, 2011 Novavax, Inc. (Nasdaq: NVAX) ... final safety and immunogenicity results from its 2009 H1N1 ... Mexico at the invitation-only 7th World Health Organization Meeting ... Trials. The meeting was held at the WHO headquarters ...
... FUJIFILM Medical Systems U.S.A., Inc. will be ... enabling remote access to Fujifilm,s suite of Synapse ... or Windows-based PCs.  Differentiated from other mobile applications by ... medical images in any platform that it,s accessed, Synapse ...
Cached Medicine Technology:NOVAVAX Presents Final Results from H1N1 Influenza Vaccine Trial at World Health Organization Meeting 2NOVAVAX Presents Final Results from H1N1 Influenza Vaccine Trial at World Health Organization Meeting 3NOVAVAX Presents Final Results from H1N1 Influenza Vaccine Trial at World Health Organization Meeting 4NOVAVAX Presents Final Results from H1N1 Influenza Vaccine Trial at World Health Organization Meeting 5Fujifilm's Synapse® Mobility Extends Imaging Reach 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: